Teva Pharmaceutical Industries Ltd.(NYSE: TEVA; TASE: TEVA) | Jewish Business News

Home Tags Teva Pharmaceutical Industries Ltd.(NYSE: TEVA; TASE: TEVA)

Teva secures $34 billion financing for Allergan acquisition

Jewish Business News Correspondent - August 2, 2015 0

Teva buys Allergan Generics for $40.5 billion

Jewish Business News Correspondent - July 27, 2015 0

Teva rejected opportunity to acquire Perrigo

Shiri Habib-Valdhorn - May 11, 2015 0

ELDAD TAMIR CAPITAL, LINKEDIN

Tamir Capital soars after court ruling against Teva

Koby Yeshayahou - April 28, 2015 0

Teva to pay $512 million in Provigil settlement – report

Moshe Golan - April 20, 2015 0

Teva to Distribute Eagle Pharmaceutical’s Cancer Drug in U.S

Jewish Business News Correspondent - February 17, 2015 0

Teva buying back $1Billion of debt

Globes - February 12, 2015 0

US Supreme Court upholds Copaxone patent

Nadav Neuman - January 21, 2015 0

Perrigo good acquisition candidate for Teva – report

Globes - January 12, 2015 0

FDA approves Teva allergy spray for children

Jewish Business News Correspondent - December 21, 2014 0

12 3...8 Page 1 of 8